HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Toru Kiguchi Selected Research
Toru Kiguchi Research Topics
Disease
7
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022 - 02/2007
7
Neoplasms (Cancer)
06/2022 - 10/2002
5
Multiple Myeloma
04/2021 - 04/2019
4
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2018 - 01/2009
3
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2022 - 02/2007
3
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2003 - 10/2002
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022 - 04/2009
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2022 - 05/2017
2
Lymphoma (Lymphomas)
03/2020 - 10/2002
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2018 - 11/2018
1
Hematologic Neoplasms (Hematological Malignancy)
06/2022
1
Injection Site Reaction
06/2022
1
Wilms Tumor (Wilm's Tumor)
06/2022
1
Chronic Renal Insufficiency
04/2022
1
Residual Neoplasm
04/2021
1
Chromosome Aberrations (Chromosome Abnormalities)
12/2020
1
Neutropenia
05/2020
1
Peripheral Nervous System Diseases (PNS Diseases)
05/2020
1
Anemia
05/2020
1
Thrombocytopenia (Thrombopenia)
05/2020
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2020
1
Multi-centric Castleman's Disease
02/2019
1
B-Cell Lymphoma (Lymphoma, B Cell)
05/2018
1
Paraproteinemias (Monoclonal Gammopathy)
05/2018
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2017
1
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2017
1
Rheumatoid Arthritis
09/2017
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2017
1
Disease Progression
09/2017
1
Tumor Lysis Syndrome
10/2016
1
Hyperuricemia
10/2016
1
Neoplasm Metastasis (Metastasis)
11/2012
1
Disseminated Intravascular Coagulation
11/2012
1
Stomach Neoplasms (Stomach Cancer)
11/2012
1
Acute Promyelocytic Leukemia
03/2010
1
Hemolysis
02/2010
1
Blast Crisis (Blast Phase)
01/2010
1
Aplastic Anemia (Anemia, Hypoplastic)
05/2009
Drug/Important Bio-Agent (IBA)
4
Pharmaceutical Preparations
IBA
06/2022 - 07/2003
4
Imatinib Mesylate (Gleevec)
FDA Link
02/2018 - 01/2009
3
Rituximab (Mabthera)
FDA Link
05/2022 - 04/2009
3
Doxorubicin (Adriamycin)
FDA Link
Generic
04/2009 - 01/2003
3
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
11/2003 - 10/2002
2
Azacitidine (5 Azacytidine)
FDA Link
08/2022 - 05/2022
2
Bendamustine Hydrochloride
FDA Link
05/2022 - 05/2017
2
Biological Products
IBA
10/2020 - 09/2017
2
Bortezomib (Velcade)
FDA Link
05/2020 - 08/2019
2
plerixafor
FDA Link
11/2018 - 11/2018
2
Interleukin-8 (Interleukin 8)
IBA
11/2003 - 01/2003
1
alvocidib (flavopiridol)
IBA
06/2022
1
Mitoxantrone (Novantrone)
FDA Link
Generic
06/2022
1
Cytarabine (Cytosar-U)
FDA Link
Generic
06/2022
1
Daunorubicin (Cerubidine)
FDA Link
Generic
06/2022
1
Peptides (Polypeptides)
IBA
06/2022
1
venetoclax
IBA
04/2022
1
Paraproteins
IBA
04/2021
1
Immunoglobulin G (IgG)
IBA
04/2021
1
elotuzumab
IBA
04/2021
1
isatuximab
IBA
12/2020
1
Proteins (Proteins, Gene)
FDA Link
10/2020
1
Lenalidomide (CC 5013)
FDA Link
05/2020
1
Dexamethasone (Maxidex)
FDA Link
Generic
05/2020
1
Melphalan (Alkeran)
FDA Link
Generic
05/2020
1
Prednisolone (Predate)
FDA Link
Generic
05/2020
1
Core Binding Factors (Core-Binding Factor)
IBA
01/2020
1
Thalidomide (Thalomid)
FDA Link
04/2019
1
Fibrin Fibrinogen Degradation Products
IBA
05/2018
1
Immunoglobulin M (IgM)
IBA
05/2018
1
Fibrinogen (Factor I)
FDA Link
05/2018
1
romidepsin (FK228)
FDA Link
11/2017
1
Methotrexate (Mexate)
FDA Link
Generic
09/2017
1
fludarabine
IBA
05/2017
1
Uric Acid (Urate)
IBA
10/2016
1
rasburicase (Elitek)
FDA Link
10/2016
1
Febuxostat
FDA Link
10/2016
1
Allopurinol (Remid)
FDA Link
Generic
10/2016
1
Xanthine Oxidase
IBA
10/2016
1
Docetaxel (Taxotere)
FDA Link
11/2012
1
Dacarbazine (DIC)
FDA Link
Generic
11/2012
1
Aligeron (AS 2)
IBA
03/2010
1
Arsenic Trioxide (Trisenox)
FDA Link
03/2010
1
Micafungin (FK463)
FDA Link
02/2010
1
Dasatinib (BMS 354825)
FDA Link
01/2010
1
Tyrosine Kinase Inhibitors
IBA
01/2010
1
nilotinib
FDA Link
01/2010
1
Deferasirox
FDA Link
05/2009
1
Chelating Agents
IBA
05/2009
Therapy/Procedure
8
Therapeutics
06/2022 - 02/2007
4
Drug Therapy (Chemotherapy)
08/2022 - 02/2007
3
Transplantation
01/2021 - 01/2010
2
Immunotherapy
06/2022 - 04/2021
2
Remission Induction
01/2021 - 02/2007
2
Stem Cell Transplantation
08/2019 - 01/2010
2
Autologous Transplantation
11/2018 - 11/2018
1
Aftercare (After-Treatment)
04/2021
1
Off-Label Use
01/2021
1
Cell- and Tissue-Based Therapy (Cell Therapy)
08/2019
1
Plasma Exchange
02/2019
1
Biological Therapy
09/2017
1
Combination Drug Therapy (Combination Chemotherapy)
11/2012